AVORAN 2.5mg tablets medication leaflet

N02CC07 frovatriptan • Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Frovatriptan is a medication used for the treatment of acute migraines, with or without aura. It belongs to a class of drugs known as serotonin receptor agonists (5-HT1), which work by constricting blood vessels in the brain and reducing inflammation associated with migraines. It is effective in relieving pain and other migraine symptoms, such as nausea and sensitivity to light or sound.

Frovatriptan is usually administered in the form of oral tablets, and the dosage is determined by the doctor based on the severity of the migraine and the patient's response to treatment. It is important to take it as soon as possible after the onset of migraine symptoms to maximize its effectiveness.

Common side effects include dizziness, fatigue, a sensation of pressure or pain in the chest, and dry mouth. In rare cases, it may cause more severe reactions, such as increased blood pressure or allergic reactions. Patients with cardiovascular conditions should use this medication with caution.

Frovatriptan is a valuable treatment for migraines, but its use requires strict adherence to the doctor's instructions. It is essential for patients to inform their doctor about any pre-existing conditions or medications they are taking to avoid drug interactions.

General data about AVORAN 2.5mg

Substance: frovatriptan

Date of last drug list: 01-06-2025

Commercial code: W70278005

Concentration: 2.5mg

Pharmaceutical form: tablets

Quantity: 6

Product type: generic

Price: 41.62 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CHANELLE MEDICAL UNLIMITED COMPANY - IRLANDA

Holder: BESTA MED LTD. - BULGARIA

Number: 15416/2024/05

Shelf life: 30 months